Technology28 May 2026SEO 801 min read

Analysis: H1 secures $40M from CVS, proving SaaS startups can still attract investment

It’s no secret that pre-AI era startups are generally getting little love from investors now. Ariel Katz, co-founder and CEO of a nine-year-old healthcare data…

It’s no secret that pre-AI era startups are generally getting little love from investors now. Ariel Katz, co-founder and CEO of a nine-year-old healthcare data platform H1 , argues that not all SaaS companies should be painted with the same broad brush. “If you’re a workflow SaaS company, you could vibe code that,” he told TechCrunch. What AI cannot easily replicate, according to Katz, is a company that is a data provider at its core. That’s a self-serving viewpoint — H1’s entire business…

Why this update matters

This developing story is relevant for readers tracking technology because it reflects fresh changes from the original source and signals where attention is shifting next.

Key details

The report was collected automatically and prepared for publication with a newsroom workflow that focuses on clarity, search visibility, and quick understanding.

Readers should review the original source for direct statements, official notices, and any later corrections or additions as the story evolves.

Related coverage

Continue reading with more reporting from the same topic cluster.

Analysissecures40MfromCVSprovingSaaSstartups